By Rick Carew And Fanny Liu 

HONG KONG--Oaktree Group LLC is exiting its flagship Asian private equity investment, Fusheng Group, according to people familiar with the situation, in a deal that could value the business around $1 billion and signals the shift of the big U.S. investor away from buying controlling stakes to potential distressed investments in Asia.

Oaktree has hired UBS AG to sell its seven-year-old stake in the Taiwanese conglomerate, according to people with knowledge of the matter.

The sale process of Fusheng, which was worth US$850 million when Oaktree bought it in 2007, is still at an early stage and it is unclear which bidders could emerge.

Oaktree owns a 48% stake in the conglomerate, which manufactures golfing equipment, air compressors, and electronic products. A key provision in its agreement that was triggered in March allowed it to sell its stake, or "drag along" its majority partner, Taiwan's Lee family, in a sale of the business, even though Oaktree holds the smaller stake.

The "drag along" provision, negotiated in the original deal, gives Oaktree certain protections and a greater degree of control over the sale process, despite the share structure. It is unclear whether the final sale will result in buyers purchasing only Oaktree's shares or full control of the business. It is also possible that the Lee family could increase their ownership.

A company official at Fusheng told The Wall Street Journal that the majority shareholders won't contest the sale by Oaktree, whose seven-year-ownership is relatively long for private-equity firms in Asia. "We understand that it is about time for a private-equity firm like Oaktree to seek an exit," the Fusheng official said. "We won't oppose that."

Oaktree made a splash when it took Fu Sheng Industrial Co. private in 2007, valuing the business at over $850 million in one of the largest foreign private equity deals in Taiwan at that point. Effectively, Oaktree bought out the public shareholders. The Lee family rolled over its 52% into the business and the two shareholders worked together to restructure the businesses under the Fusheng Group banner.

Write to Rick Carew at rick.carew@gmail.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

THC Farmaceuticals (PK) (USOTC:CBDG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more THC Farmaceuticals (PK) Charts.
THC Farmaceuticals (PK) (USOTC:CBDG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more THC Farmaceuticals (PK) Charts.